Welcome to our dedicated page for Vystar SEC filings (Ticker: VYST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Vystar Corporation filings document its status as a reporting operating company and its compliance calendar for periodic SEC reports. The available Form 12b-25 notification covers the delayed Form 10-K for the annual period ended December 31, 2025, and records the registrant name, SEC file number, CUSIP, form type, reporting period and stated late-filing basis.
Vystar Corporation reported very small Q2 2026 revenue of $7,767, down from $11,615 a year earlier, and a Q2 net loss attributable to Vystar of $225,293. For the first six months of 2026, revenue was $13,914 with a net loss of $590,072.
Cash from continuing operations was $109,845 at June 30, 2026, but current liabilities totaled $7.7 million, producing a working capital deficit of about $7.2 million and an accumulated deficit near $62 million. Total stockholders’ deficit was $7.1 million, and derivative liabilities were $469,153. Management states there is substantial doubt about the company’s ability to continue as a going concern and highlights dependence on new financing and revenue growth.
Operations rely heavily on air purification units (85% of year-to-date sales), and one customer represented 53% of Q2 revenue. Subsequent to quarter-end, Vystar entered a joint venture to co-own r3alm, Inc., issuing 8,371 Series B preferred shares, and holds a court-awarded attorneys’ fee recovery of about $497,440 from resolved EMA litigation.
Vystar Corp reports that investor Barry Martin Bordetsky beneficially owns a significant block of its common stock. Bordetsky reports ownership of 164,589,333 shares of Vystar common stock, representing 11.37% of the class, held with sole voting and dispositive power and no shared authority.
Bordetsky is a United States citizen with a business address in Parsippany-Troy Hills, New Jersey, while Vystar’s principal executive offices are located in Worcester, Massachusetts. The ownership is described as "pre-reverse acquisition", indicating the reported stake relates to that capital structure.
Vystar Corporation entered into a joint venture with Capital Realm, Inc. to acquire a 50% interest in r3alm inc., a compliance-focused AI and Web3 financial ecosystem aimed at bridging traditional finance and decentralized technologies. Capital Realm has spent a decade developing the R3alm platform, which currently comprises 22 planned modules covering digital capital formation, tokenized real-world assets, digital securities infrastructure, governance, trading and liquidity tools, treasury systems, identity and wallet functions, collectibles infrastructure, analytics, and an AI-powered financial intelligence layer.
As consideration for the 50% interest, Vystar issued 8,371 shares of Series B Preferred Stock to Capital Realm, convertible into 8,371,000 shares of common stock, described as representing 34% and becoming fully vested upon proof of the intellectual property concept. The issuance was made as an unregistered offering relying on an exemption under Regulation D of the Securities Act of 1933. Related agreements include a Series B Preferred Stock Subscription Agreement, a Stock Purchase, Share Exchange and Equity Acquisition Agreement, a True Up Rights and 34% Ownership Maintenance Agreement, and a Shareholders Agreement governing the joint venture relationship.
Vystar Corporation reported another quarterly loss and continued financial strain for the three months ended March 31, 2026. Revenue fell to $6,147 from $12,657 a year earlier, while gross profit was essentially flat at $4,272. Operating expenses of $281,122 produced a loss from operations of $276,850 and a net loss of $364,779, or $0.01 per share.
Liquidity remains extremely tight. Cash was only $9,907 against total current liabilities of $7,338,549, resulting in a working capital deficit of about $7 million and a stockholders’ deficit of $6,900,522. Management notes an accumulated deficit of roughly $61.7 million and explicitly states there is substantial doubt about the company’s ability to continue as a going concern.
The balance sheet is burdened by related party debt, including a Blue Oar term convertible note with a 12% rate and associated derivative liabilities of $423,632, plus defaulted notes and arrears to the Rotman family. Capital remains highly structured, with three series of cumulative convertible preferred stock that could convert into 30,712,937 common shares, far exceeding the 24,621,094 common shares currently outstanding.
There are a few offsetting developments. Vystar successfully prevailed in long-running EMA Financial litigation and was awarded $497,439.58 in attorneys’ fees, and it holds federal net operating loss carryforwards of about $39.2 million. Subsequent to quarter-end, the company signed a binding letter of intent to acquire 50% of Capital R3alm, Inc. in exchange for Series B preferred shares that would give Capital R3alm a 34% ownership stake in Vystar, aiming to expand into a Web3-focused financial technology ecosystem alongside its existing RxAir air purification and Vytex latex businesses.
Vystar Corporation filed its annual report for the year ended December 31, 2025, showing a net loss attributable to Vystar of $1,531,658 as revenue fell to $54,821, down about 60% from 2024. The decline was driven by lower Vytex and RxAir sales, including reduced orders from a former major customer and the absence of a prior-year bulk Vytex sale.
The company ended 2025 with only $4,454 of cash, a working capital deficit of roughly $6.6M and an accumulated deficit of about $61.4M. Auditors highlighted substantial doubt about Vystar’s ability to continue as a going concern. Operations are being funded through related-party debt, stock subscriptions and small equity issuances, while management seeks to boost RxAir distribution and Vytex licensing.
Rotmans furniture operations remain classified as discontinued. In long-running litigation with EMA Financial, the courts upheld prior rulings in Vystar’s favor and the District Court awarded Vystar $497,439.58 in attorneys’ fees and costs, which EMA has appealed. The company also continues to invest in product and technology initiatives, including new RxAir models, expanded Vytex applications through its Corrie MacColl partnership, and Fluid Energy Conversion prototypes, despite limited financial resources.
VYSTAR CORPORATION notified the SEC it cannot timely file its Form 10-K for the period ended December 31, 2025 because it is unable to complete the 10-K and provide it to auditors for review without unreasonable effort or expense. The company states it believes it will file within the 15-calendar day extension under Rule 12b-25.
Vystar Corporation reported Q3 2025 results showing very limited sales and ongoing losses. Revenue was $20,385, led by air purification units of $14,812 (72.7% of sales). Gross profit was $15,365, offset by operating expenses of $262,341, resulting in an operating loss of $246,976 and a net loss of $271,387 (basic and diluted loss per share $0.01). For the nine months, revenue was $44,657 with a net loss of $1,236,593.
Liquidity remains strained: cash was $16,584, current liabilities totaled $6,725,826 against current assets of $390,602, and stockholders’ deficit was $(6,242,094). Management states there is substantial doubt about the company’s ability to continue as a going concern.
The balance sheet includes a related party term note (Blue Oar) with a carrying amount of approximately $750,000 and a related derivative liability of $356,142. Share-based compensation expense was $199,097 in Q3. Common shares outstanding were 22,485,017 as of November 12, 2025.